Steven Roth to In Situ Nick-End Labeling
This is a "connection" page, showing publications Steven Roth has written about In Situ Nick-End Labeling.
Connection Strength
0.792
-
Bone-marrow mesenchymal stem-cell administration significantly improves outcome after retinal ischemia in rats. Graefes Arch Clin Exp Ophthalmol. 2017 Aug; 255(8):1581-1592.
Score: 0.149
-
Hypoxic-Preconditioned Bone Marrow Stem Cell Medium Significantly Improves Outcome After Retinal Ischemia in Rats. Invest Ophthalmol Vis Sci. 2016 06 01; 57(7):3522-32.
Score: 0.140
-
Delayed administration of bone marrow mesenchymal stem cell conditioned medium significantly improves outcome after retinal ischemia in rats. Invest Ophthalmol Vis Sci. 2014 Apr 03; 55(6):3785-96.
Score: 0.120
-
Post-ischemic conditioning in the rat retina is dependent upon ischemia duration and is not additive with ischemic pre-conditioning. Exp Eye Res. 2010 Dec; 91(6):844-52.
Score: 0.092
-
Involvement of erythropoietin in retinal ischemic preconditioning. Anesthesiology. 2009 Apr; 110(4):774-80.
Score: 0.085
-
Protein kinase C subtypes and retinal ischemic preconditioning. Exp Eye Res. 2008 Oct; 87(4):300-11.
Score: 0.080
-
Mitogen-activated protein kinases and retinal ischemia. Invest Ophthalmol Vis Sci. 2003 Dec; 44(12):5383-95.
Score: 0.059
-
Ischemic preconditioning attenuates apoptotic cell death in the rat retina. Invest Ophthalmol Vis Sci. 2002 Sep; 43(9):3059-66.
Score: 0.054
-
Erythropoietin administration protects retinal neurons from acute ischemia-reperfusion injury. Proc Natl Acad Sci U S A. 2002 Aug 06; 99(16):10659-64.
Score: 0.013